ARS Pharmaceuticals
Price & Volume
Stats
See more52W Range | $9.33-$18.90 |
Market Cap | $997.1M |
Shares Short | 21M |
Financials
See moreRevenue (12 Mos) | $112.3M |
Revenue Growth (YoY) | 3,043.4% |
Gross Profit (12 Mos) | $90.8M |
Diluted EPS | -$0.49 |
News
See moreYahoo Finance • 4 days ago
ARS Pharmaceuticals Secures Up to $250 Million Loan Facility with RA Capital Management and OMERS Life Sciences to Accelerate U.S. Commercialization of neffy®
Yahoo Finance • 14 days ago
Sector Update: Health Care Stocks Mixed Late Afternoon
Yahoo Finance • 14 days ago
neffy® (epinephrine nasal spray) Approved in Japan as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
Yahoo Finance • last month
ARS Pharma drops 9% as Lupin files application for generic neffy
About
CEO | Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL |
Address | 11682 El Camino Real, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 162 |
